The new OOD was compared to OTD at identical total daily doses ( TDD : @-@mg / day ) employing intensive , five times daily current pain ( @-@mm visual analog scale , VAS ) and twice daily @h recalled pain assessments as well as safety parameters such as nausea and sedation ( VAS ) over @ days for each treatment ( after a @day run-in phase ) .